Using gene editing with CRISPR-Cas9, the team has been able to study these proteins without altering ... Dec. 13, 2024 — Microorganisms produce a wide variety of natural products that can be ...

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR ...

With efforts towards gender equality stalling, voting in a first female head of the UN would provide powerful representation for half the world’s population — and be good for all of it.

CRISPR-Cas systems are prokaryotic immune systems that confer resistance to foreign genetic elements such as plasmids and phages. CRISPR-Cas systems have been exploited for targeted genome editing ...

In a bold and ambitious attempt to reverse extinction, Colossal Biosciences, a Texas-based de-extinction company, is ...

(Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical ... expedite clinical development and regulatory review timelines -- -- Additional FDA designation for CB-010 ...

The Heart Failure Drugs Market is poised for a transformative decade between 2025 and 2035. As heart failure continues to ...

Cellistic, a pioneer in induced pluripotent stem cells (iPSC)-based cell therapies, is launching the Echo™-NK platform to enable the scalable manufacturing of allogeneic cell therapies to target ...

Cellistic has launched the Echo-NK platform to enable the scalable manufacturing of allogeneic cell therapies to target multiple diseases.